The US FDA Grants Clearance to Indica Labs’ HALO AP Dx Digital Pathology Platform
Shots:
- The US FDA has cleared the company’s HALO AP Dx digital pathology platform to be used with Hamamatsu NanoZoomer S360MD Slide scanner for in vitro diagnosis
- The platform facilitates remote work & consultations as well as immediate access to scanned slides from any location, enabling uninterrupted pathology services & global collaboration without the need to ship slides
- HALO AP Dx platform provides solutions for primary diagnosis, collaboration, tumor boards & second opinions. Its integration engine combines various software and hardware capabilities for better pathology practices
Ref: Indica Labs | Image: Indica Labs
Related News:- Indica Labs Collaborated with iCAIRD to Develop AI-Based Algorithm for the Detection of Lymph Node Status in Colon Cancer
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
